Search company, investor...

Predict your next investment

Boston Scientific company logo
Corporation
HEALTHCARE | Medical Devices & Equipment
bostonscientific.com

Investments

69

Portfolio Exits

19

Partners & Customers

10

Service Providers

1

About Boston Scientific

Boston Scientific (NYSE: BSX) develops and manufactures medical devices. It provides critical care products, electrophysiology products, gastroenterology products, pulmonology products, and more. The company offers pacemakers, defibrillators, coronary stents, and others. Boston Scientific caters to medical practitioners, patients, and research and development students. The company was founded in 1979 and is based in Marlborough, Massachusetts.

Headquarters Location

300 Boston Scientific Way

Marlborough, Massachusetts, 01752,

United States

+1 (800) 876-9960

Want to inform investors similar to Boston Scientific about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Boston Scientific

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Boston Scientific in 2 Expert Collections, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

M

Medical Devices

4,328 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

Research containing Boston Scientific

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Boston Scientific in 4 CB Insights research briefs, most recently on Feb 21, 2022.

Latest Boston Scientific News

Remote patient monitoring market size to increase by USD 1,733.81 million: North America will account for 46% of the market's growth during the forecast period - Technavio

Jan 26, 2023

News provided by Share this article Share this article NEW YORK, Jan. 26, 2023 /PRNewswire/ -- The Remote Patient Monitoring Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 22.22% and register an incremental growth of USD 1,733.81 million during the forecast period. The report provides a comprehensive analysis on growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF Sample Report Regional Analysis Technavio has announced its latest market research report titled Global Remote Patient Monitoring Market 2023-2027 By region, the global remote patient monitoring market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 46% of the market's growth during the forecast period. The growing awareness of the benefits of remote patient monitoring solutions, increasing work pressure across healthcare facilities, growing advances in patient data collection technologies, and the rising prevalence of chronic diseases are driving the growth of the regional market. Company Profiles The remote patient monitoring market report includes information on the key products and recent developments of leading vendors, including: Abbott Laboratories: The company offers remote patient monitoring such as FreeStyle LibreLink App, and LibreView. Advantech Co. Ltd: The company offers remote patient monitoring such as Advantech POC 6 series Boston Scientific Corp: The company offers remote patient monitoring such as LATITUDE NXT Patient Management System. Draegerwerk AG and Co. KGaA: The company offers remote patient monitoring such as Infinity PiCCO SmartPod, and Infinity M540. Honeywell International Inc: The company offers remote patient monitoring such as the CARESCAPE ONE system. Koninklijke Philips NV Market Dynamics The market is driven by factors such as the cost benefits of remote patient monitoring, the emergence of digital healthcare services and healthcare 4.0, and the need for healthcare facilities in remote areas. However, the complexities associated with the deployment of smart healthcare solutions are hindering market growth. Competitive Analysis The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample Market Segmentation By product, the market is segmented into vital signs and implantable. The vital signs segment accounted for the largest share of the market during the forecast period. By geography, the market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America held the largest share of the market during the forecast period. Related Reports: Patient Monitoring Equipment Market in Japan  by Product and End-user - Forecast and Analysis 2022-2026: The patient monitoring equipment market share in Japan is expected to increase by USD 366.62 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.79%. The growing preference for self-care monitoring devices is notably driving the patient monitoring equipment market growth in Japan, although factors such as data privacy issues may impede the market growth. Laboratory Shaker Market  by Product, Application, and Geography - Forecast and Analysis 2023-2027: The laboratory shaker market is estimated to grow at a CAGR of 7.09% between 2022 and 2027. The size of the market is forecast to increase by USD 611.28 million. The increased use of laboratory shakers in various applications is notably driving the market growth, although factors such as the high cost of laboratory shakers may impede the market growth. Key companies profiled Abbott Laboratories, Advantech Co. Ltd., Alten SA, Boston Scientific Corp., Caretaker Medical NA, Draegerwerk AG and Co. KGaA, Honeywell International Inc., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, MphRx Inc., Napier Healthcare Solutions Pte Ltd., Nihon Kohden Corp., OMRON Corp., OSI Systems Inc., OSP Labs, Shenzhen Mindray BioMedical Electronics, Siemens AG, Smiths Group Plc, and General Electric Co. Market dynamics Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Browse for Technavio " Health Care " Research Reports Table of Contents Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global remote patient monitoring market 2017 - 2021 Exhibit 18: Historic Market Size – Data Table on Global remote patient monitoring market 2017 - 2021 ($ million) 4.2 Product Segment Analysis 2017 - 2021  Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million) 4.3 End user Segment Analysis 2017 - 2021  Exhibit 20: Historic Market Size – End user Segment 2017 - 2021 ($ million) 4.4 Geography Segment Analysis 2017 - 2021  Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million) 4.5 Country Segment Analysis 2017 - 2021  Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million) 5 Five Forces Analysis Exhibit 33: Data Table on Comparison by Product 6.3 Vital signs - Market size and forecast 2022-2027 Exhibit 34: Chart on Vital signs - Market size and forecast 2022-2027 ($ million) Exhibit 35: Data Table on Vital signs - Market size and forecast 2022-2027 ($ million) Exhibit 36: Chart on Vital signs - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Vital signs - Year-over-year growth 2022-2027 (%) 6.4 Implantable - Market size and forecast 2022-2027 Exhibit 38: Chart on Implantable - Market size and forecast 2022-2027 ($ million) Exhibit 39: Data Table on Implantable - Market size and forecast 2022-2027 ($ million) Exhibit 40: Chart on Implantable - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Implantable - Year-over-year growth 2022-2027 (%) 6.5 Market opportunity by Product  Exhibit 42: Market opportunity by Product ($ million) 7 Market Segmentation by End-user 7.1 Market segments  Exhibit 46: Data Table on Comparison by End-user 7.3 Hospitals - Market size and forecast 2022-2027 Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) 7.4 ASCs - Market size and forecast 2022-2027 Exhibit 51: Chart on ASCs - Market size and forecast 2022-2027 ($ million) Exhibit 52: Data Table on ASCs - Market size and forecast 2022-2027 ($ million) Exhibit 53: Chart on ASCs - Year-over-year growth 2022-2027 (%) Exhibit 54: Data Table on ASCs - Year-over-year growth 2022-2027 (%) 7.5 Home care - Market size and forecast 2022-2027 Exhibit 55: Chart on Home care - Market size and forecast 2022-2027 ($ million) Exhibit 56: Data Table on Home care - Market size and forecast 2022-2027 ($ million) Exhibit 57: Chart on Home care - Year-over-year growth 2022-2027 (%) Exhibit 58: Data Table on Home care - Year-over-year growth 2022-2027 (%) 7.6 Market opportunity by End-user  Exhibit 59: Market opportunity by End-user ($ million) 8 Customer Landscape Exhibit 64: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 China - Market size and forecast 2022-2027 Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%) 9.9 Germany - Market size and forecast 2022-2027 Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.10 Canada - Market size and forecast 2022-2027 Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%) 9.11 UK - Market size and forecast 2022-2027 Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography  Exhibit 101: Market opportunity by geography ($ million) 10 Drivers, Challenges, and Trends 10.1 Market drivers Exhibit 102: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11.3 Landscape disruption  11.4 Industry risks  About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Boston Scientific Investments

69 Investments

Boston Scientific has made 69 investments. Their latest investment was in SetPoint Medical as part of their Series F on January 1, 2023.

CBI Logo

Boston Scientific Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/19/2023

Series F

SetPoint Medical

$80M

No

4

9/1/2021

Series C

Nectero Medical

$19.5M

Yes

9

8/4/2021

Series A

Append Medical

$7.4M

Yes

5

3/5/2021

Corporate Minority

Subscribe to see more

Subscribe to see more

10

9/21/2020

Corporate Minority - II

Subscribe to see more

Subscribe to see more

10

Date

1/19/2023

9/1/2021

8/4/2021

3/5/2021

9/21/2020

Round

Series F

Series C

Series A

Corporate Minority

Corporate Minority - II

Company

SetPoint Medical

Nectero Medical

Append Medical

Subscribe to see more

Subscribe to see more

Amount

$80M

$19.5M

$7.4M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

9

5

10

10

Boston Scientific Portfolio Exits

19 Portfolio Exits

Boston Scientific has 19 portfolio exits. Their latest portfolio exit was RenovoRx on August 26, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/26/2021

IPO

$99M

Public

7

12/7/2020

Acq - Fin

$99M

1

5/12/2020

Divestiture

Boston Scientific - Intrauterine Health Product Line

$99M

1

7/2/2019

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

7/10/2018

Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/26/2021

12/7/2020

5/12/2020

7/2/2019

7/10/2018

Exit

IPO

Acq - Fin

Divestiture

Divestiture

Merger

Companies

Boston Scientific - Intrauterine Health Product Line

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

7

1

1

10

10

Boston Scientific Acquisitions

59 Acquisitions

Boston Scientific acquired 59 companies. Their latest acquisition was Acotec on December 11, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/11/2022

Other Venture Capital

$99M

Corporate Majority

12

11/29/2022

Debt

$99M

$184.07M

Acq - Pending

1

8/15/2022

Seed / Angel

$99M

$3.23M

Acquired

11

6/15/2022

Subscribe to see more

$99M

Subscribe to see more

10

6/15/2022

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/11/2022

11/29/2022

8/15/2022

6/15/2022

6/15/2022

Investment Stage

Other Venture Capital

Debt

Seed / Angel

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$184.07M

$3.23M

Note

Corporate Majority

Acq - Pending

Acquired

Subscribe to see more

Subscribe to see more

Sources

12

1

11

10

10

Boston Scientific Partners & Customers

10 Partners and customers

Boston Scientific has 10 strategic partners and customers. Boston Scientific recently partnered with Truveta on September 9, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

9/27/2022

Licensor

United States

Health data company Truveta inks partnership with Boston Scientific, releases COVID-19 data

The partnership will enable Boston Scientific researchers to access Truveta 's de-identified data from more than 65 million U.S. patients , with the aim of gathering insights into devices and disease states .

4

8/16/2022

Partner

United States

General Electric : Wipro GE Healthcare Collaborates with Boston Scientific to Advance Cardiac Care in India

Earlier this year , GE Healthcare signed a similar partnership with Boston Scientific in Southeast Asia which also offers combined cardiology solutions to customers including in training and education .

2

5/24/2022

Partner

United States

10:07 EDT Urology Care Foundation Announces Medical Student Innovation Fellowship in Collaboration with Boston Scientific Corpor...

The Urology Care Foundation announces Medical Student Innovation Fellowship in collaboration with Boston Scientific Corporation .

1

1/5/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

1/1/2022

Partner

Finland

Subscribe to see more

Subscribe to see more

0

Date

9/27/2022

8/16/2022

5/24/2022

1/5/2022

1/1/2022

Type

Licensor

Partner

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

United States

Finland

News Snippet

Health data company Truveta inks partnership with Boston Scientific, releases COVID-19 data

The partnership will enable Boston Scientific researchers to access Truveta 's de-identified data from more than 65 million U.S. patients , with the aim of gathering insights into devices and disease states .

General Electric : Wipro GE Healthcare Collaborates with Boston Scientific to Advance Cardiac Care in India

Earlier this year , GE Healthcare signed a similar partnership with Boston Scientific in Southeast Asia which also offers combined cardiology solutions to customers including in training and education .

10:07 EDT Urology Care Foundation Announces Medical Student Innovation Fellowship in Collaboration with Boston Scientific Corpor...

The Urology Care Foundation announces Medical Student Innovation Fellowship in collaboration with Boston Scientific Corporation .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

2

1

10

0

Boston Scientific Service Providers

1 Service Provider

Boston Scientific has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Boston Scientific Team

69 Team Members

Boston Scientific has 69 team members, including , .

Name

Work History

Title

Status

John Abele

Kingbridge

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

John Abele

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Kingbridge

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Boston Scientific to Competitors

C
Cala Health

Cala Health develops wearable neuromodulation therapies to deliver individualized peripheral nerve stimulation. It was founded in 2014 and is based in San Mateo, California.

Saluda Medical Logo
Saluda Medical

Saluda Medical is a global medical device company developing a platform of closed-loop neuromodulation technologies, based on the neural response to stimulation, to aid people suffering from chronic back pain and other debilitating conditions. The company's first device is the Evoke Spinal Cord Stimulation (SCS) System, a closed-loop SCS that is currently being evaluated in a randomized, double-blinded clinical trial.

Nuvaira Logo
Nuvaira

Nuvaira is a privately held company headquartered in Minneapolis, MN. The company’s proprietary Nuvaira Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD). The Nuvaira Lung Denervation System is under clinical investigation and is not commercially available in the USA, and is CE Mark approved.

Cardionomic Logo
Cardionomic

Cardionomic addresses Acute Decompensated Heart Failure's root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality.

S
ShiraTronics

ShiraTronics develops an approach to treat migraine headaches. The company is focused on developing and clinically testing its neuromodulation technology

Lungpacer Medical Logo
Lungpacer Medical

Lungpacer Medical develops a therapeutic solution for preserving or restoring the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical ventilation. The Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach. Through this approach, the company seeks to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. The company was founded in 2009 and is based in Vancouver, British Columbia.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.